Tale from the Crypt: Belantamab Mafodotin

from OncoPharm · host John Bossaer

[Moving Trailer Voice] This Halloween: They always come back.... The latest revival is belantamab mafodotin, FDA approved...again. After being vanquished in DREAMM3, it returned in DREAMM7 and even Daratumumab (in combination with Vd) couldn't overcome this blindingly effective drug (in combination with Vd). This pod reviews belantamab mafodotin's checkered past and wonders what the sequels may have in store for us.

Episode metadata supplied by the publisher feed · Published Oct 30, 2025

Embed this episode

Attribution link and audio player

Ready to play

Tale from the Crypt: Belantamab Mafodotin

0:00 14:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncoPharm?

This episode is 14 minutes long.

When was this OncoPharm episode published?

This episode was published on October 30, 2025.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!